Loading…

State-of-the-art cancer biomarker detection by portable (Bio) sensing technology: A critical review

[Display omitted] •The monitoring of most cancer biomarkers with trace amounts of body fluids needs high bio affinity sensors.•POCT devices have shown their wide range of uses, from the monitoring of health to the diagnostic of diseases.•The goal of this review is to discuss the technological progre...

Full description

Saved in:
Bibliographic Details
Published in:Microchemical journal 2022-06, Vol.177, p.107248, Article 107248
Main Authors: Sohrabi, Hessamaddin, Bolandi, Nadia, Hemmati, Afsaneh, Eyvazi, Shirin, Ghasemzadeh, Shahin, Baradaran, Behzad, Oroojalian, Fatemeh, Reza Majidi, Mir, de la Guardia, Miguel, Mokhtarzadeh, Ahad
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •The monitoring of most cancer biomarkers with trace amounts of body fluids needs high bio affinity sensors.•POCT devices have shown their wide range of uses, from the monitoring of health to the diagnostic of diseases.•The goal of this review is to discuss the technological progress of bio-affinity portable devices for cancer biomarkers.•The development of portable biosensors is supported by nanotechnology, microfluidic, electrical, and networking skills.•To develop a novel and wearable bio-affinity system, a perspective is finally made and major technical hurdles highlighted. Electrochemical portable assays by applying data analysis capability enabled patients to use real-time medical instruments and health-related information. The trace determination of the most cancer biomarkers in body fluids by mobile health (mHealth) equipment requires high bio-affinity sensors that depend on the applied “bioreceptors”. Portable point-of-care (POCT) sensing devices have shown their wide range of applications, ranging from the monitoring of health systems to the diagnostic and treatment of most cancers. Portable-based biosensors are small, cost effective, sensitive, and online detection equipment provide real-time determination of biological agents. Nanomaterial-based compounds, microfluidic systems, electrical and biological design methods and the wireless networking skills are significantly required for design and development of mobile-based biosensing assays. The goal of this review is to discuss the recent progress of mHealth bio-affinity technology from laboratory testing to mobile POCT tools and electronic portable assays for the detection of cancer biomarkers. First of all, the mechanism of portable-based detecting approaches and their analytical characteristics will be described in detailed with related researchworks. Next, different detecting techniques will be discussed and an effective evaluation will be carried out for the identification of cancer biomarkers. Moreover, recent recognition advances will be described alongside their recognition process (e.g., various electrochemical and optical methods) in the mHealth affinity biosensors, which are enabled by numerous bioreceptors (e.g. DNAs, antibodies, molecularly imprinted polymers and aptamers). In order to create a novel sensing models on the wearable bio-affinity system, the challenges and perspective are finally made and major technical hurdles will be highlighted.
ISSN:0026-265X
1095-9149
DOI:10.1016/j.microc.2022.107248